CCDC 1827708: Experimental Crystal Structure Determination
Lawrence R. Marcin(Bristol-Myers Squibb (United States)), John E. Macor(Bristol-Myers Squibb (United States)), Grandhi V. R. K. M. Gupta(Bristol-Myers Squibb (India)), Bradley C. Pearce(Bristol-Myers Squibb (Germany)), Hyunsoo Park(Chungnam National University), Pattipati S. Naidu(Bristol-Myers Squibb (India)), Arvind Mathur(Bristol-Myers Squibb (United States)), Bettadapura N. Srikumar(National Institute of Mental Health and Neurosciences), M. S. Paschapur(Bristol-Myers Squibb (India)), Michelle Nophsker(Bristol-Myers Squibb (United States)), Linda J. Bristow(Bristol-Myers Squibb (United States)), Alicia Ng(Bristol-Myers Squibb (United States)), Rajareddy Kallem(Syngene International (India)), Jayakumar Warrier(Bristol-Myers Squibb (India)), Manjunath Ramarao(Bristol-Myers Squibb (United States)), Srinivas Jogi(Bristol-Myers Squibb (India)), Tanmaya Bastia(Bristol-Myers Squibb (India)), Srinivas Cheruku(Bristol-Myers Squibb (India)), Srinivasan Thangathirupathy(Bristol-Myers Squibb (India)), Kumar Kuchibhotla Vijaya(Bristol-Myers Squibb (India)), Thaddeus F. Molski(Circle (United States)), Jyoti Gulia(Bristol-Myers Squibb (India)), Ganji Purnachandra Nagaraju(University of Alabama at Birmingham Hospital), Dalton King(Circle (United States)), Lorin A. Thompson(DuPont (United States)), Narasimharaju Kalidindi(Bristol-Myers Squibb (India)), Charlie Albright(Editas Medicine (United States)), James Kempson(Bristol-Myers Squibb (United States)), Reeba K. Vikramadithyan(Bristol-Myers Squibb (India)), Gopikishan Tonukunuru(Bristol-Myers Squibb (India)), Richard E. Olson(Los Alamos National Laboratory), Michael Sinz(Rutgers, The State University of New Jersey), Jean Simmermacher, George N. Karageorge(Bristol-Myers Squibb (United States)), Joanne J. Bronson(Bristol-Myers Squibb (United States)), Jayant Aher(Bristol-Myers Squibb (India)), Charulatha Sanmathi(Bristol-Myers Squibb (India)), Manjunatha Kamble(Bristol-Myers Squibb (India)), Aliphedi B. Reddy(Bristol-Myers Squibb (India)), Jianqing Li(Nanjing University of Chinese Medicine), Huiping Zhang(Huazhong University of Science and Technology), Jianliang Shi(Bristol-Myers Squibb (United States)), Rex Denton(Bristol-Myers Squibb (United States)), Eric Shields(Bristol-Myers Squibb (United States)), Murali Subramanian(Bristol-Myers Squibb (India)), Imadul Islam(King Saud bin Abdulaziz University for Health Sciences), Xiaoliang Zhuo(Bristol-Myers Squibb (United States)), Raju Mannoori(Bristol-Myers Squibb (India))
Cited by 0
Related Papers
CYP3A4 Induction by Drugs: Correlation between a Pregnane X Receptor Reporter Gene Assay and CYP3A4 Expression in Human Hepatocytes
|Drug Metabolism and Disposition|2002|447
MEK inhibitors: The chemistry and biological activity of U0126, its analogs, and cyclization products
|Bioorganic & Medicinal Chemistry Letters|1998|406
RAGE potentiates Aβ‐induced perturbation of neuronal function in transgenic mice
|The EMBO Journal|2004|327
Inactivation of Cytochrome P450 3A4 by Bergamottin, a Component of Grapefruit Juice
|Chemical Research in Toxicology|1998|312